Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

  • This share is currently suspended. It was suspended at a price of 1.65
  • There is currently no data for MDO

Interim Management Statement

10 Nov 2022 09:42

RNS Number : 9939F
Mandarin Oriental International Ltd
10 November 2022
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

10th November 2022 - Mandarin Oriental International Limited today issues its Interim Management Statement for the third quarter of 2022.

 

The return of normal travel conditions in most of the world in early 2022 saw the Group record net underlying profits (unaudited) in the second quarter, and this progress continued in the third quarter.

 

In the Group's owned hotels, improvements in occupancy and high rates resulted in a stronger performance in the third quarter. This drove increased profitability compared to the second quarter, particularly in Paris and Munich. Two of the Group's key profit-generating hotels, in Hong Kong and Tokyo, however, remained subject to stringent travel restrictions throughout the third quarter, which significantly impacted operating performance. The hotels in Bangkok and Singapore continued their recovery following the removal of travel barriers.

 

The performance of the management business was strong in the third quarter and it recorded a significant improvement in profitability compared to the second quarter. Of particular note were the contributions made by a number of the Group's Mediterranean and Middle Eastern properties.

 

As a result of the improved trading conditions and Mandarin Oriental's expanded portfolio of hotels and residences, the Group recorded its highest quarterly EBITDA since 2019. Both the owned hotels and the management business delivered higher EBITDA than in the second quarter of 2022.

 

In September 2022, the Group opened Mandarin Oriental Palace, Luzern, its second hotel in Switzerland, and its standalone residences project in Barcelona. Recently, the Group announced a new hotel in Tianfu, the new business district of Chengdu, further expanding its presence in China. On 8th September 2022, the Group completed the sale of Mandarin Oriental, Washington D.C., for US$139 million. As a result, the Group has recognised a post-tax, non-trading gain in the third quarter of US$47 million.

 

Following the disposal, net debt at 30th September 2022 reduced to US$385 million (US$519 million at 30th June 2022), and the Group held US$267 million of cash reserves and US$472 million in available, committed debt facilities. Gearing was 8% of adjusted shareholders' funds.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the standard segment of the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

Mandarin Oriental Hotel Group International Limited

James Riley

(852) 2895 9288

Matthew Bishop

(852) 2895 9288

Brunswick Group Limited

William Brocklehurst

(852) 5685 9881

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKBLBFLFLXFBK
Date   Source Headline
9th May 201212:32 pmRNSInterim Management Statement
3rd May 201212:21 pmRNSAnnual Information Update
2nd May 201210:48 amRNSDividend
30th Apr 20121:06 pmRNSTotal Voting Rights
27th Apr 201211:00 amRNSDirector Declaration
11th Apr 201210:10 amRNSAnnual Financial Report
3rd Apr 201212:00 pmRNSDirector/PDMR Shareholding
2nd Apr 201212:13 pmRNSDirector Declaration
30th Mar 201210:50 amRNSTotal Voting Rights
26th Mar 201212:15 pmRNSBlocklisting Interim Review
20th Mar 201211:37 amRNSDirector/PDMR Shareholding
20th Mar 20128:51 amRNSAdditional Listing
19th Mar 201210:28 amRNSDirector/PDMR Shareholding
16th Mar 201210:43 amRNSDirector/PDMR Shareholding
15th Mar 201210:50 amRNSDirector/PDMR Shareholding
14th Mar 201210:31 amRNSDirector/PDMR Shareholding
1st Mar 20129:06 amRNSDirectorate Change and Declaration
1st Mar 20129:06 amRNSFinal Results
6th Feb 201211:20 amRNSNotice of 2011 Final Results
30th Dec 20119:14 amRNSDirectorate Change
9th Nov 20119:10 amRNSInterim Management Statement
31st Oct 201111:13 amRNSTotal Voting Rights
6th Oct 201111:57 amRNSDirector/PDMR Shareholding
3rd Oct 201110:22 amRNSDirector Declaration
29th Sep 201111:15 amRNSDirectorate Change
28th Sep 201110:24 amRNSDividend
26th Sep 201110:21 amRNSBlocklisting Interim Review
28th Jul 201110:05 amRNSHalf Yearly Report
30th Jun 201110:27 amRNSNotice of 2011 Half-Yearly Results
31st May 201110:42 amRNSTotal Voting Rights
12th May 20111:14 pmRNSDirectorate Change
11th May 20112:18 pmRNSAGM Statement
11th May 20112:11 pmRNSResult of AGM
11th May 201112:31 pmRNSInterim Management Statement
5th May 201111:28 amRNSDirector/PDMR Shareholding
4th May 201110:16 amRNSDividend
3rd May 201111:37 amRNSAnnual Information Update
7th Apr 201110:37 amRNSAnnual Financial Report
31st Mar 201110:46 amRNSDirector/PDMR Shareholding
31st Mar 201110:40 amRNSTotal Voting Rights
25th Mar 20119:22 amRNSBlocklisting Interim Review
22nd Mar 20118:54 amRNSAdditional Listing
16th Mar 20119:24 amRNSDirector/PDMR Shareholding
3rd Mar 20119:05 amRNSFinal Results
7th Feb 20119:14 amRNSNotice of 2010 Final Results
31st Dec 20107:12 amRNSTotal Voting Rights
15th Dec 201010:11 amRNSDirector/PDMR Shareholding
14th Dec 20109:37 amRNSDirector/PDMR Shareholding
13th Dec 201010:01 amRNSDirector/PDMR Shareholding
10th Dec 20109:55 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.